Resultados globales: 1 registros encontrados en 0.02 segundos.
Artículos, Encontrados 1 registros
Artículos Encontrados 1 registros  
1.
13 p, 850.9 KB Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation / Chhabra, Saurabh (Medical College of Wisconsin) ; Liu, Ying (Medical College of Wisconsin) ; Hemmer, Michael T. (Medical College of Wisconsin) ; Costa, Luciano (University of Alabama at Birmingham. Department of Medicine) ; Pidala, Joseph A. (H. Lee Moffitt Cancer Center and Research Institute) ; Couriel, Daniel R. (Utah Blood and Marrow Transplant Program) ; Alousi, Amin M. (University of Texas MD Anderson Cancer Center) ; Majhail, Navneet S. (Cleveland Clinic Taussig Cancer Institute) ; Stuart, Robert K. (Medical University of South Carolina) ; Kim, Dennis (Princess Margaret Cancer Center) ; Ringden, Olle (Karolinska Institutet (Estocolm, Suècia). Division of Therapeutic Immunology) ; Urbano Ispizua, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Saad, Ayman (University of Alabama at Birmingham) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Cooper, Brenda (University Hospitals Case Medical Center. Department of Medicine-Hematology and Oncology) ; Marks, David I. (University Hospitals Bristol NHS Trust) ; Socie, Gerard (Hôpital Saint Louis. Department of Hematology) ; Schouten, Harry C. (Academische Ziekenhuis. Department of Hematology) ; Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ; Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ; Yared, Jean (University of Maryland. Greenebaum Cancer Center) ; Cahn, Jean-Yves (CHU Grenoble Alpes. Department of Hematology) ; Wagner, John (Thomas Jefferson University. Department of Medical Oncology) ; Antin, Joseph H. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Verdonck, Leo F. (Isala Clinic. Departmentt of Hematology/Oncology) ; Lehmann, Leslie (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; MacMillan, Margaret L. (University of Minnesota Blood and Marrow Transplant Program) ; Litzow, Mark R. (Mayo Clinic Rochester. Division of Hematology and Transplant Center) ; Solh, Melhem M. (Northside Hospital. Blood and Marrow Transplant Group of Georgia) ; Qayed, Muna (Emory University School of Medicine. Department of Pediatrics) ; Hematti, Peiman (University of Wisconsin) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Vij, Ravi (Washington University School of Medicine. Division of Hematology and Oncology) ; Hayashi, Robert J. (Washington University School of Medicine in St. Louis. Division of Pediatric Hematology/Oncology) ; Gale, Robert Peter (Imperial College London. Hematology Research Centre) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Seo, Sachiko (National Cancer Research Center East) ; Hashmi, Shahrukh K (Mayo Clinic Rochester. Division of Hematology and Transplant Center) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; Teshima, Takanori (Kyushu University Hospital) ; Gergis, Usama (New York Presbyterian Hospital/Weill Cornell Medical Center. Department of Medical Oncology) ; Inamoto, Yoshihiro (National Cancer Center Hospital) ; Spellman, Stephen R. (Center for International Blood and Marrow Transplant Research) ; Arora, Mukta (University of Minnesota Medical Center) ; Hamilton, Betty K. (Cleveland Clinic Taussig Cancer Institute) ; Universitat Autònoma de Barcelona
The combination of a calcineurin inhibitor (CNI) such as tacrolimus (TAC) or cyclosporine (CYSP) with methotrexate (MTX) or with mycophenolate mofetil (MMF) has been commonly used for graft-versus-host disease (GVHD) prophylaxis after reduced-intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (alloHCT), but there are limited data comparing efficacy of the 2 regimens. [...]
2019 - 10.1016/j.bbmt.2018.08.018
Biology of blood and marrow transplantation, Vol. 25 Núm. 1 (january 2019) , p. 73-85  

Vea también: autores con nombres similares
1 Stuart, Robert K.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.